Strides Arcolab Surges 3 Percent on US FDA Nod for Topotecan

Pharmaceutical company Strides Arcolab gained 3percent intraday on Wednesday as its wholly owned subsidiary Onco Therapies has received ANDA (abbreviated new drug application) approval from the US FDA for Topotecan Hydrochloride injection 4 mg (base) packaged in single dose vials.
Moneycontrol.com